| Financial Year |
March 31 2023 |
| Monetary Funds |
5,074,975,024.94 |
| Held-for-trading Financial Assets |
9,407,178.90 |
| Notes Receivable |
21,036,314.28 |
| Accounts Receivable |
132,322,763.79 |
| Advances to Suppliers |
48,978,426.94 |
| Other Receivables |
31,934,299.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
746,502.55 |
| Dividend Receivable |
-- |
| Inventories |
1,909,967,353.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,940,941,188.89 |
| Other Current Assets |
3,940,866,019.42 |
| Total Current Assets |
15,361,898,310.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
731,167.98 |
| Long-term Equity Investment |
175,644,445.81 |
| Investment Properties |
-- |
| Fixed Assetes |
1,826,557,790.57 |
| Under-construction Projects |
1,068,836,820.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
397,252,054.05 |
| R&D expenses |
2,535,616.25 |
| Goodwill |
89,949,008.98 |
| Long-Term Deferred and Prepaid Expenses |
20,601,457.33 |
| Deferred Income Tax Assets |
418,991,183.69 |
| Other Non-Current Assets |
159,131,631.63 |
| Sub-Total of Non-Current Assets |
5,014,004,059.45 |
| Total Assets |
20,375,902,369.84 |
| Short-Term Loans |
2,359,664,867.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
197,504,686.36 |
| Accounts Payable |
2,356,485,955.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
222,003,299.59 |
| Taxes Payable |
159,537,466.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
681,750,182.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
222,409,673.54 |
| Other Current Liabilities |
64,920,146.96 |
| Sub-Total of Current Liabilities |
7,410,096,920.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
303,182,578.32 |
| Deferred Income Tax Liabilities |
44,084,885.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
480,379,549.91 |
| Total Liabilities |
7,890,476,470.45 |
| Paid-In Capital(Or Share Stock) |
701,239,045.00 |
| Capital Surplus |
4,038,307,561.46 |
| Surplus Reserve |
350,619,522.50 |
| LESS:Treasury Stock |
165,292,125.00 |
| Undistributed Profits |
7,268,678,175.97 |
| Minority Stockholder's Interest |
236,467,857.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,248,958,042.31 |
| Owner's Equity（Stockholder's Equity） |
12,485,425,899.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,375,902,369.84 |
